NVAX FY 2015 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$36M+18.2% YoY

Gross Profit

-$126M-348.7% margin

Operating Income

-$157M-433.8% margin

Net Income

-$157M-432.9% margin

EPS (Diluted)

$-11.97

Cash Flow

Operating Cash Flow

-$126M

Free Cash Flow

-$144M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$386M

Total Liabilities

$93M

Stockholders' Equity

$293M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$31M	+18.2%
Gross Profit	-$126M	$16M	-906.5%
Operating Income	-$157M	-$84M	-87.9%
Net Income	-$157M	-$83M	-89.2%